Diet control to achieve euglycemia induces significant loss of heart and liver weight via increased autophagy compared with ad libitum diet in diabetic rats

Experimental and Molecular Medicine

Volumn 46, Issue 8, 2014, Pages

  Lee, Jun Ho ^a   Lee, Ju Han ^a,b   Jin, Mingli ^a   Han, Sang Don ^a   Chon, Gyu Rak ^a   Kim, Ick Hee ^a   Kim, Seonguk ^a   Kim, Sung Young ^a   Choi, Soo Bong ^a   Noh, Yun Hee ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Rmedica Stem Cell   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CALORIC RESTRICTION; CONTROLLED STUDY; DIET RESTRICTION; EUGLYCEMIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART WEIGHT; HYPERGLYCEMIA; HYPERPLASIA; HYPOGLYCEMIA; INSULIN DEFICIENCY; KIDNEY DISEASE; LIVER WEIGHT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS RESECTION; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; ALBUMINURIA; ANIMAL; BLOOD; DIET; DIET THERAPY; EATING; EXPERIMENTAL DIABETES MELLITUS; GLUCOSURIA; HEART MUSCLE; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; URINE;

ALBUMINURIA; ANIMALS; AUTOPHAGY; CHOLESTEROL, HDL; DIABETES MELLITUS, EXPERIMENTAL; DIET; EATING; GLYCOSURIA; INSULIN; LIVER; MALE; MYOCARDIUM; ORGAN SIZE; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN;

EID: 84906848581     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2014.52     Document Type: Article

References (42)

1. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
2. Shamoon H, Duffy H, Fleischer N, Engel S, Saenger P, Strelzyn M et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977-986.
3. Skyler JS. Diabetic complications. The importance of glucose control. Endocrinol Metab Clin North Am 1996; 25: 243-254.
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988; 260: 2864-2871.
5. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. New Engl J Med 1993; 329: 304-309.
6. Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: A prospective epidemiological analysis. Diabetologia 2005; 48: 1749-1755.
7. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year followup of intensive glucose control in type 2 diabetes. New Engl J Med 2008; 359: 1577-1589.
8. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB et al. Effects of intensive glucose lowering in type 2 diabetes. New Engl J Med 2008; 358: 2545-2559.
9. Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovascular disease: An update. Nat Rev Cardiol 2010; 7: 369-375.
10. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011; 343: d4169.
11. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL et al. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet 2010; 375: 481-489.
12. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-1379.
13. American Diabetes Association. Standards of medical care in diabetes- 2011. Diabetes Care 2011; 34 (Suppl 1), S11-S61.
14. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ et al. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2008; 31(Suppl 1), S61-S78.
15. Noh YH, Lee WJ, Kim KA, Lim I, Lee JH, Kim S et al. Insulin requirement profiles of patients with type 2 diabetes after achieving stabilized glycemic control with short-term continuous subcutaneous insulin infusion. Diabetes Technol Ther 2010; 12: 271-281.
16. Shintani T, Klionsky DJ. Autophagy in health and disease: A double-edged sword. Science 2004; 306: 990-995.
17. Kourtis N, Tavernarakis N. Autophagy and cell death in model organisms. Cell Death Differ 2009; 16: 21-30.
18. Wang RC, Levine B. Autophagy in cellular growth control. FEBS Lett 2010; 584: 1417-1426.
19. Turner RC, Holman RR, Cull CA, Stratton IM, Matthews DR, Frighi V et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
20. Turner RC, Holman RR, Stratton IM, Cull CA, Matthews DR, Manley SE et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-865.
21. Cella SG, Locatelli V, Mennini T, Zanini A, Bendotti C, Forloni GL et al. Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function. Endocrinology 1990; 127: 1625-1634.
22. Harding JE. The nutritional basis of the fetal origins of adult disease. Int J Epidemiol 2001; 30: 15-23.
23. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938-941.
24. Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell 2008; 19: 2092-2100.
25. Komatsu M, Kageyama S, Ichimura Y. p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 2012; 66: 457-462.
26. Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 2006; 116: 2161-2172.
27. Kunchithapautham K, Rohrer B. Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy 2007; 3: 433-441.
28. Yu L, Wan F, Dutta S, Welsh S, Liu Z, Freundt E et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA 2006; 103: 4952-4957.
29. Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H. Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy 2006; 2: 212-214.
30. Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma H. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 2001; 65: 965-968.
31. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275: 992-998.
32. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P et al. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 2001; 276: 35243-35246.
33. Li SY, Fang CX, Aberle NS 2nd, Ren BH, Ceylan-Isik AF, Ren J. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function. J Endocrinol 2005; 186: 491-503.
34. Mariappan MM, Shetty M, Sataranatarajan K, Choudhury GG, Kasinath BS. Glycogen synthase kinase 3beta is a novel regulator of high glucoseand high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells. J Biol Chem 2008; 283: 30566-30575.
35. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54: 1615-1625.
36. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15: 1101-1111.
37. Goodman MN, Ruderman NB. Starvation in the rat. I. Effect of age and obesity on organ weights, RNA, DNA, and protein. Am J Physiol 1980; 239: E269-E276.
38. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325: 201-204.
39. Hansen BC, Bodkin NL. Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes 1993; 42: 1809-1814.
40. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995; 44: 1249-1258.
41. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New Engl J Med 2006; 355: 2427-2443.
42. Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. New Engl J Med 2007; 357: 1716-1730.